Bats Global Markets Announces Launch of Debt Refinancing Transaction

Expected to Close in June

KANSAS CITY, Mo.--(BUSINESS WIRE)-- Bats Global Markets, Inc. (Bats: BATS), a leading global operator of exchanges and services for financial markets, today announced plans to refinance its existing $656 million Term Loan B facilities and $100 million revolving credit facility.

The term loan transaction is expected to be financed through a new $650 million Term Loan B, and funding is scheduled to close in June. There can be no assurance that the refinancing will be completed, in whole or in part.

About Bats Global Markets, Inc.

Bats Global Markets, Inc. (Bats: BATS) is a leading global operator of exchanges and services for financial markets, dedicated to Making Markets Better. Bats is the second-largest stock exchange operator in the U.S., operates the largest stock exchange and trade reporting facility in Europe, and the #1 market globally for ETF trading. We also operate growing ETF listings venues in the U.S. and Europe, two U.S. options exchanges and Bats Hotspot, our global foreign exchange market. ETF.com, a leading provider of ETF news, data and analysis, is a wholly-owned subsidiary. The company is headquartered in Kansas City with offices in New York, London, Chicago, San Francisco and Singapore. Visit bats.com and @BatsGlobal for more information.

Forward-Looking Statements

This press release includes certain disclosures which contain “forward-looking statements.” You can identify forward-looking statements because they contain words such as “believes” and “expects.” Forward-looking statements are based on Bats’ current expectations and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that may differ materially from those contemplated by the forward-looking statements, which are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in our filings with the SEC, including our registration statement on Form S-1, as amended from time to time, under the caption “Risk Factors.”

View source version on businesswire.com: http://www.businesswire.com/news/home/20160610005602/en/

Bats Global Markets
MEDIA
Randy Williams
New York
+1.212.378.8522
[email protected]
or
INVESTORS
Mark Marriott
Kansas City
+1.913.815.7132
[email protected]

Source: Bats Global Markets, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Zipalertinib combo meets Phase 3 trial goal in lung cancer study
• Outlook Therapeutics launches public offering of stock and warrants
• NeOnc Phase 2a brain cancer trial shows 48.9% survival vs. 20% benchmark